Connect with us

Government

Biden Administration Moving Forward With Trump-Era Proposal For US Uranium Reserve

Biden Administration Moving Forward With Trump-Era Proposal For US Uranium Reserve

The Biden administration is taking steps to establish a US uranium reserve, a proposal put forward by the Trump administration which could boost mining of…

Published

on

Biden Administration Moving Forward With Trump-Era Proposal For US Uranium Reserve

The Biden administration is taking steps to establish a US uranium reserve, a proposal put forward by the Trump administration which could boost mining of the mineral as well as the potential to expand nuclear energy in the United States.

"Yellowcake" uranium coming off a conveyor line

In Tuesday testimony before the Senate Energy and Natural Resources Committee, Energy Secretary Jennifer Granholm said that her department is laying the groundwork for such a move.

"We’re about to issue a request for information [RFI] regarding establishing a reserve," she said, adding "We are, I think this month, issuing an RFI on that."

Jennifer Granholm

In a major funding bill passed late last year, Congress set aside funds to establish the strategic reserve, which would buy US-mined uranium from domestic producers, which we assume is separate from the US reserves bought by Russia during Hillary Clinton's Uranium One scandal.

When asked why the Biden administration's budget request for 2022 didn't include funding for the reserve, Granholm cited the existing funding for the project.

"It had been appropriated for last year so it’s carrying over," she said.

A 2020 Trump administration report endorsed spending millions on the reserve, which would aim to boost domestic mining.

The concept is similar to that of the already existing strategic petroleum reserve, where the government can hold up to 714 million barrels of that fuel in case of an emergency.  -The Hill

Zero Hedge readers will recall our coverage on the uranium sector, which we said in April was set to benefit from several factors - including upcoming infrastructure spending, the reddit short squeeze crowd, an extremely bullish case laid out by a BofA analyst, and a passionate tweetstorm by former hedge fund manager Hugh Hendry, who said "A lot of you are invested in uranium. I commend you. I wish I was. Uranium is the rockstar of commodities. It doesn't mess around - bull and bear markets are of epic proportions."

Furthermore, Michael "big short" Burry advocated for converting US to nuclear power as a way for Democrats to create jobs in a 'green' industry.

Related stocks moved higher on the news.

And to review what we said in April:

The first reason is a mix of regulatory and market developments.

As we reported earlier today, the spot price for U3O8 moved above $30 per pound for the first time this year as uranium producers and mine developers hoovered up above-ground inventories and reactor construction continues apace. Two new research notes from BMO Capital Markets and Morgan Stanley say today’s price marks a floor and predict a rally in prices over the next few years to the ~$50 level by 2024, which - all else equal - would translate into soaring stock prices for names such as CCJ, UEC, URA and URNM.

Indeed, as Mining.com said, the stars seem to be aligning for a new phase of nuclear energy investment with the US, China and Europe bolstering the bull case for the fuel this month.

And while nuclear energy was not (yet) mentioned explicitly in the $2 trillion Biden infrastructure proposal released today, its federally mandated “energy efficiency and clean electricity standard” is hardly achievable without it. 

Curiously, the big regulatory move may be coming out of Europe, where - as we expected - Uranium is now officially part of the cool ESG crowd as over the weekend leaked documents showed a panel of experts advising the EU is set to designate nuclear as a sustainable source of electricity which opens the door for new investment under the continent’s ambitious green energy program.

Then there is China - as Mining.com notes, China’s 14th five-year plan released a fortnight ago also buoyed the uranium market with Beijing planning to up the country’s nuclear energy capacity by 46% – from 48GW in 2020 to 70GW by 2025. There are several factors working in uranium’s favor, not least the fact that annual uranium demand is now above the level that existed before the 2011 Fukushima disaster when Japan shut off all its reactors:

  • Uranium miners, developers and investment funds like Yellow Cake (13m lbs inventory build up so far) are buying material on the spot market bringing to more normal levels government and utility inventories built up over the last decade

  • Major mines are idled including Cameco’s Cigar Lake (due to covid-19) which accounts for 18m lbs or 13% of annual mine supply.  The world’s largest uranium operation McArthur River was suspended in July 2018 taking 25m lbs off the market

  • Permanent closures so far this year include Rio Tinto’s Ranger operation in Australia (3m lbs) and Niger’s Cominak mine (2.6m lbs) which had been in operation since 1978. Rio is exiting the market entirely following the sale of Rössing Uranium in Namibia

  • Like Cameco, top producer Kazatomprom, which mined 15% less material last year due to covid restrictions has committed to below capacity production (–20% for the state-owned Kazakh miner) for the foreseeable future

  • Price reporting agency and research company UxC estimates that utilities’ uncovered requirements would balloon to some 500m lbs by 2026 and 1.4 billion lbs by 2035  

  • Roughly 390m lbs are already locked up in the long term market while 815m lbs have been consumed in reactors over the last five years, according to UxC

  • There are 444 nuclear reactors in operation worldwide and another 50 under construction – 2 new connections to the grid and one construction start so far in  2021

  • Much cheaper and safer, small modular nuclear power reactors which can readily slot into brownfield sites like decommissioned coal-fired plants (or even underground or underwater) are expected to become a significant source of additional demand.

The last bullet brings us to reason number 2: the coming "small modular reactor" frenzy:

As Nikkei Asia reports today, one of Japan's top industrial engineering companies will join a US-led project to build a new type of nuclear power plant designed with added precautions against meltdowns. These plants will be built in the US, where they will propel the uranium sector to level it hasn't seen in decades (indicatively CCJ traded roughly double where it is today as just before the 2008 financial crisis).

According to the Nikkei, Japan's JGC Holdings will help build a plant in the state of Idaho designed by NuScale Power, an American company whose proposal for a small modular reactor (SMR) involves immersing the containment units in a pool of water.

Small nuclear reactors have been hailed as an option for replacing fossil fuel power plants as nations commit to cutting carbon dioxide emissions in the coming decade

And here, we get one step closer to Uranium becoming part of ESG: when Joe Biden meets Japanese Prime Minister Yoshihide Suga for a summit in the U.S. later this month, fighting climate change will be on the agenda and "small nuclear" - and uranium - will be high on the agenda.

JGC has invested $40 million for a roughly 3% stake in NuScale, one player in the emerging field of SMRs. The Japanese group will work with NuScale's parent, U.S.-based engineering company Fluor, on construction management and other aspects of the Idaho project.

One thing is clear: as the SMR strategy takes off, much more uranium will be needed, as the partners eventually could set their sights on similar projects in the Middle East - where JGC boasts a long track record in oil and petrochemical infrastructure - and Southeast Asia. In fact, the entire world could soon be covered in small, safe nukes which will lead to an unprecedented renaissance for the uranium sector.

Why the scramble for SMR?

The first reason is simple: price. Nuclear plants on the scale of 1,000 megawatts cost around $10 billion to build using established reactor designs. NuScale's SMR design - which completed a technical review by the U.S. Nuclear Regulatory Commission in August 2020, ahead of rival proposals - reportedly costs around $3 billion for more than 900 MW. The Idaho plant will have a capacity between 600 MW and more than 700 MW, according to announced plans. NuScale also has a strategic partnership with South Korea's Doosan Heavy Industries and Construction, which will supply components for the plant.

The second, and far more important reason, is safety. Japan's Fukushima nuclear disaster a decade ago shows what happens when reactor cooling systems break down. The loss of emergency power after a devastating 2011 tsunami led to reactor meltdowns at the Fukushima Daiichi plant operated by Tokyo Electric Power Co. Holdings. Well, NuScale's SMR design seeks to remove this risk, as the water in the pool takes a month to evaporate and helps keep the reactor's temperature down.

The U.S. government supports research and development in small-scale reactors. A Green Growth Strategy announced by Japan last year calls for "providing active support" to Japanese companies participating in experimental overseas projects in this field. Many existing nuclear plants in Japan, the U.S. and other advanced economies have been in operation for decades and require upgrades or decommissioning.

In short, between recent bullish market dynamics, and a sector that is on the cusp of becoming the next ESG craze, the promise of new SMR technologies could ensure uranium demand is stable for decades, leading to a new golden age for uranium stocks.

Tyler Durden Tue, 06/15/2021 - 14:15

Read More

Continue Reading

Science

4 Biotech Stocks For Your August 2021 Watchlist

Investors could be shifting their focus to biotech stocks, should you do the same?
The post 4 Biotech Stocks For Your August 2021 Watchlist appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.

Published

on

top biotech stocks to watch

4 Top Biotech Stocks To Watch This Month

As investors look for the next lucrative industry in the stock market, biotech stocks would often be in sight. It may not be the largest industry nor the most exciting, but it does boast some of the highest potential for returns. For example, a biotech company posting positive clinical trial results or gaining FDA approval will likely see big gains. Meanwhile, a delay or negative results could send a company’s stock in the wrong direction. 

We need to look no further than Moderna Inc (NASDAQ: MRNA) and Pfizer Inc (NYSE: PFE) when it comes to the importance health care brings to the table. Out of the blue, we were struck by a global pandemic that has changed everyone’s lives. This has then made people realize the important roles that biotech stocks play in crucial times like this. Demand for coronavirus vaccines remains high as fears of the delta variant escalate. With the potential need for booster shots in discussion, Moderna and Pfizer are able to raise the prices of their jabs in their latest European Union (EU) supply contracts. With that being said, are you also on the lookout for the top biotech stocks in the stock market today

Top Biotech Stocks To Buy [Or Sell] In August 2021

BioNTech SE

Firstly, we have the German biotech company, BioNTech. Put simply, it develops and commercializes immunotherapies for cancer and other infectious diseases. Over the past year, the company became known globally through its partnership with Pfizer to develop the coronavirus vaccine that is being used today. BNTX stock has skyrocketed over the past month due to fears of coronavirus escalating. It has risen over 45% just within the one-month period. 

In July, the company along with Pfizer announced that the U.S. government purchased an additional 200 million doses of its coronavirus vaccine. With this, the total number of doses supplied by the companies to the U.S. government will be at 500 million. These additional doses are expected to be delivered from October 2021 through April 2022. The U.S. government’s confidence in the vaccine puts both companies in a favorable position. After all, vaccines have been and will remain critical in protecting lives against the pandemic.

On another note, BioNTech has also announced the launch of its Malaria project last Monday. This project aims to develop a well-tolerated and highly effective Malaria vaccine and implement sustainable vaccine supply solutions on the African continent. Its efforts will include cutting-edge research and innovation, investments in vaccine development, and establishing manufacturing facilities across the continent. Given the company’s track record in tackling infectious diseases, there are reasons to believe this will be successful long-term. All things considered, would you consider buying BNTX stock?

biotech stocks (BNTX stock)
Source: TD Ameritrade TOS

Read More

Zai Lab Ltd

China-based biopharmaceutical company Zai Lab focuses on developing and commercializing therapeutics in oncology, autoimmune and infectious diseases. As of now, it has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. A few examples would be Niraparib, Zl-2103, ZL-1101, and others. 

Last Tuesday, the company and Entasis Therapeutics Holdings Inc (NASDAQ: ETTX) announced that patient enrollment in the ATTACK Phase 3 registrational clinical trial of sulbactam-durlobactam is now complete. This will be the largest antibiotic-resistant, pathogen-specific registrational trial conducted globally. Also, it is the first to focus specifically on carbapenem-resistant Acinetobacter infections. Should top-line data be announced in the coming months, it would be a huge step for both companies. 

Besides that, Zai Lab also collaborated with MacroGenics (NASDAQ: MGNX) to develop and commercialize preclinical bispecific antibodies in oncology during its second quarter. Under the terms of the agreement, Zai Lab receives commercial rights in China, Japan, and Korea while MacroGenics will have the rights in all other territories. Now, the collaboration leverages both companies’ unique research capabilities and gives Zai Lab access to MacroGenics’ proprietary technologies to expand its innovative oncology portfolio. With these in mind, would ZLAB stock be a top biotech stock to buy?

best biotech stocks (ZLAB stock)
Source: TD Ameritrade TOS

[Read More] Best Communication Stocks To Watch Right Now

Vertex Pharmaceuticals Incorporated

Next up, we may have one of the top biotech companies that have flown under the radar of many investors, Vertex. For the uninitiated, the company focuses on developing and commercializing therapies for the treatment of cystic fibrosis (CF). Its marketed medicines are ORKAMBI and KALYDECO. 

Just last week, Vertex announced that it will initiate a Phase 3 development program for the new once-daily investigational triple combination of VX-121/tezacaftor/VX-561(deutivacaftor) in the second half of 2021. The data from its Phase 2 study were mostly encouraging. Hence, the company aims to develop a more effective treatment regimen with the potential to restore cystic fibrosis transmembrane conductance regulator function in people with CF to even higher levels than currently achievable. 

During its second quarter, Vertex showed continued, and significant growth in its CF franchise. Its product revenues came in at $1.79 billion, an increase of 18% year-over-year. Thus, allowing the company to raise its full-year guidance for product revenues to $7.2 to $7.4 billion. Moreover, Vertex has also made important progress with its pipeline programs with five programs in mid to late-stage clinical trials. So, would you consider investing in VRTX stock on the dip? 

VCYT stock
Source: TD Ameritrade TOS

[Read More] Top Gaming Stocks To Buy Now? 4 Names To Watch

Veracyte Inc

Veracyte is a genomic diagnostics company. The company utilizes ribonucleic acid (RNA), whole-transcriptome sequencing combined with machine learning, and produces genomic tests. The genomic tests include Afirma Genomic Sequencing Classifier (GSC), Percepta Bronchial Genomic Classifier, Envisia Genomic Classifier, and Afirma Xpression Atlas. 

Investors could be watching VCYT stock following the company’s recent new data announcement and second-quarter earnings report. So, Veracyte’s new data suggest the Decipher Prostate Biopsy genomic classifier (GC) may help guide treatment decisions for prostate cancer patients who are candidates for active surveillance (AS). It has found evidence that Decipher scores predict time to definitive treatment and time to treatment failure among men with early-stage prostate cancer. With this, it fills a critical gap in prostate cancer treatment. 

On the other hand, its second-quarter financial results showed significant momentum with particularly strong growth in its thyroid and urologic cancer product lines. Its total revenue was $55.1 million, up by 166% year-over-year. Meanwhile, its total volume of genomic tests grew to 20,856, an increase of 215% compared to the prior year’s quarter. If we take into account the pending HalioDx acquisition, it will further fuel Veracyte’s global cancer diagnostics growth and leadership. So, would you be watching VCYT stock right now?

VCYT stock
Source: TD Ameritrade TOS

The post 4 Biotech Stocks For Your August 2021 Watchlist appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.

Read More

Continue Reading

Stocks

Best Cheap Stocks To Buy Now? 4 Tech Stocks To Know

Could these tech stocks be worth betting on now?
The post Best Cheap Stocks To Buy Now? 4 Tech Stocks To Know appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.

Published

on

best cheap stocks to buy now (tech stocks)

Are These The Top Tech Stocks To Buy This Week?

With the current momentum in the broader stock market, investors could be considering tech stocks among other growth areas now. For starters, companies across the board continue to see stellar growth this earnings season. According to global market data analysis firm Refinitiv, overall earnings across the S&P 500 are expected to rise 76% year-over-year. Notably, this would mark its fastest growth since 2009. With the economy having gone into full swing for the past quarter, this would make sense. Now, tech stocks, in particular, could be well-positioned to leverage the current market conditions.

For the most part, the industry does not seem to be slowing down anytime soon as well. Evidently, some of the biggest names in tech known as FAANG stocks reported solid earnings over the past few weeks. To highlight, Amazon (NASDAQ: AMZN) saw significant growth across its wide portfolio. Accordingly, it posted sizable year-over-year jumps of 87% in ad revenue and 37% in cloud revenue. Elsewhere, Microsoft (NASDAQ: MSFT) is reportedly looking to invest in Oyo, one of India’s most valuable startups. Backing the leading budget hotel chain operator in the region would be a unique play by Microsoft. Nonetheless, the company appears keen to broaden its investments and current portfolio.

Overall, these are but two instances of the constant growth in the tech industry now. Most would argue that the stock market today is home to plenty more upcoming tech stocks worth knowing. Should all this have you interested to invest in some yourself, here are four to watch this week.

Best Tech Stocks To Buy [Or Sell] Today

Lam Research Corporation

Lam Research is a tech company that focuses on its innovative wafer fabrication equipment and services. Its products allow chipmakers to build smaller, faster, and better-performing electronic devices. It combines its superior systems engineering capabilities with its unwavering commitment to customer success. In fact, nearly every advanced chip is built with the company’s technology. LRCX stock currently trades at $641.80 as of Monday’s closing bell and is up by over 68% in the past year. On July 28, 2021, the company reported its June 2021 quarter financials.

Firstly, the company posted revenue of $4.15 billion for the quarter, increasing by over 45% year-over-year. Secondly, the company also saw its earnings per share increase by over 70% year-over-year at diluted earnings per share of $7.98. Lam Research says that strong semiconductor demand and rising device complexity are driving higher levels of wafer fabrication equipment investment. It also says that its edge in technology and collaboration with customers positions the company to extend its leadership across all its market segments. The company also ended the quarter with $6 billion in cash and cash equivalents. Given this piece of news, will you consider adding LRCX stock to your watchlist?

top tech stocks (LRCX stock)
Source: TD Ameritrade TOS

Read More

Virgin Galactic Holdings Inc.

Moving on, we have Virgin Galactic, a spaceflight company with headquarters in California and operations in New Mexico. The company runs a commercial spaceflight business, with regular paid passenger service flights scheduled to begin in 2022. SPCE stock closed Monday’s trading session up 6.30% at $31.87 a share. The company will be reporting its second-quarter 2021 financials on August 5, 2021, after the market closes.

On July 11, 2021, company founder Richard Branson and three other employees rode on a flight as passengers, marking the first time a spaceflight company founder has traveled on his own ship into outer space. This successful flight is a landmark achievement for the company and a historic moment for the new commercial space industry. The team behind this successful flight will also open the door for greater access to space for an industry that is still in its infancy. All things considered, will you buy SPCE stock ahead of it popularizing commercial spaceflight?

best tech stocks (SPCE stock)
Source: TD Ameritrade TOS

[Read More] 4 Top E-Commerce Stocks To Consider Buying Right Now

Roblox Corporation

Roblox is a tech company that focuses on video game development. Its tech platform enables billions of users to play, learn and communicate. Furthermore, it empowers its global community of developers who in turn produce its own immersive multiplayer experiences using Roblox Studio. In essence, the company is one of the top online entertainment platforms for audiences under the age of 18. Shares of RBLX stock closed Monday’s trading session at $78.31 apiece.

Last month, the company announced a strategic partnership that will bring more Sony Music (NYSE: SONY) recording artists to the Roblox metaverse. Both companies will work together to develop innovative music experiences for the Roblox community. It will also offer a range of new commercial opportunities for Sony Music artists to reach new audiences and generate new revenue streams around virtual entertainment. The agreement builds on an existing relationship between the two companies that included previous collaborations with big names such as Lil Nas X’s hit virtual performance on Roblox in November 2020. With that being said, will you consider RBLX stock a top tech stock to add to your radar this month?

top tech stocks (RBLX stock)
Source: TD Ameritrade TOS

[Read More] Best Stocks To Invest In 2021? 4 Dividend Stocks To Watch

ContextLogic Inc.

Another emerging name in the tech space to consider now would be ContextLogic or Wish for short. In brief, the company operates via its proprietary e-commerce platform, Wish. Through a combination of tech and data science, Wish helps to facilitate transactions and interactions between buyers and sellers. The Wish platform provides consumers with an “innovative discovery-based mobile shopping experience”. Accordingly, this would appeal to homebound consumers throughout the current pandemic. In terms of scale, Wish serves millions of consumers from over 100 countries across the globe. The company accomplishes this via its network of over half a million merchants.

Now, WISH stock ended Monday’s trading day up a modest 4.37% at $10.41 a share. Could it be worth investing in now? If anything, the company’s latest earnings figures could provide a clearer understanding on this end. Back in May, the company raked in total revenue of $772 million for the quarter. This marks a solid 75% year-over-year surge. Moreover, Wish also saw its core marketplace revenue per active buyer surge by 76% over the same time. Not to mention, the company’s logistics revenue reportedly quadrupled year-over-year. With Wish set to report its second-quarter fiscal next week, would you consider WISH stock a top cheap tech stock to watch now?

WISH stock
Source: TD Ameritrade TOS

The post Best Cheap Stocks To Buy Now? 4 Tech Stocks To Know appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.

Read More

Continue Reading

Government

As the eviction moratorium ends, we need a long-term solution to housing insecurity

The Centers for Disease Control and Prevention’s (CDC) eviction moratorium for the COVID-19 pandemic provided acute relief to people who were struggling to pay rent. That moratorium expired on July 31; however, neither abruptly ending it nor prolonging…

Published

on

By Carl Romer, Andre M. Perry

The Centers for Disease Control and Prevention’s (CDC) eviction moratorium for the COVID-19 pandemic provided acute relief to people who were struggling to pay rent. That moratorium expired on July 31; however, neither abruptly ending it nor prolonging it will solve the problem of housing insecurity, particularly in Black-majority neighborhoods and for low-income, essential workers.

The COVID-19 pandemic’s health and economic impacts hit Black communities hard because of several systemic risk factors, including higher rates of intergenerational housing, neighborhood poverty, and comorbidities. Mass evictions can only worsen outcomes.

A review of the literature published in Social Science & Medicine found broad consensus that evictions have detrimental health effects on households during normal times. Those effects have been exacerbated during the pandemic. While the moratorium delayed the execution of evictions, it was only temporary, and many households who struggled throughout the pandemic now face a high risk of housing insecurity. Although predicting how many renting households cannot pay their rent is difficult in the absence of federal data collection, a historic eviction wave is on the horizon. The Aspen Institute estimated the number of at-risk people to be between 30 million and 40 million.

One avenue for insight into the looming eviction crisis is looking at eviction filings, which the CDC moratorium did not stop. Just like before the pandemic, eviction filings have continued to disproportionately hit Black communities throughout the pandemic in the places we have data for. Using data from Princeton University’s Eviction Lab, we document eviction filings taking place from the week of March 15, 2020, through the week of June 27, 2021. The data is available for five states and 17 cities at the census-tract level.

There were 351,421 eviction filings in these areas during the pandemic. And while Black-majority neighborhoods hold 10% of these cities’ and states’ populations, they accounted for 24% of eviction filings. Comparatively, neighborhoods with less than 1% Black population also account for 10% of these cities’ and states’ populations, but they accounted for 3% of eviction filings. In the chart below, we show the percentage of eviction filings in neighborhoods by share of the Black population.

Fig1

The 351,421 eviction filings is still significantly lower than the 771,748 filings Eviction Lab predicted would have occurred during normal times. This is similar to the finding by RVA Eviction Lab at Virginia Commonwealth University, which found that evictions filings and judgements in Virginia were down 63% and 81%, respectively. This decrease was felt most significantly in Black-majority neighborhoods.

Fig2

The impending eviction crisis also reveals the housing insecurity of members of the working class, whose wages have not kept pace with housing prices. Many of them are also the pandemic’s “essential” workers.

According to the National Low Income Housing Coalition, workers deemed essential—including food service workers, home health aides, cooks and prep workers, and others—have “risked their lives during the pandemic, but don’t get paid enough to afford housing.” These workers have long been essential, but it has taken the COVID-19 pandemic for them to be acknowledged as such, and it is taking businesses even longer to raise wages to compensate them.

Essential and low-wage workers should be compensated enough to reflect the critical roles they play in the economy. The 2021 National Housing Wage—the estimated hourly wage full-time workers must earn enough to afford a modest one-bedroom rental home at the Department of Housing and Urban Development’s (HUD) fair market rent rate without spending more than 30% of their income—is $20.40 per hour. The federal minimum wage, $7.25, is well below that.

California is planning on using $5.2 billion in federal stimulus money to pay 100% of unpaid rent lower-income Californians incurred during the pandemic. The state has also extended its eviction moratorium to September 30. The state of Washington also extended its eviction moratorium to September 30 with some modifications: Beginning August 1, landlords can take action against tenants who are not paying rent or seeking rental assistance as long as they offer tenants a reasonable repayment plan before beginning the eviction process. Lawmakers in Oregon approved a 60-day eviction delay for renters who seek rent assistance.

While these types of eviction-prevention methods are helpful for recipients, they do not address the fundamental issues of America’s long-standing eviction crisis, which will require action on both housing and labor. Rental assistance programs from HUD and the Department of Agriculture are severely underfunded. So-called “right to work” laws in some states constrain labor protections, drive down wages, and make affording and paying rent more difficult. And a recent poll showed that 80% of Americans agree that the federal minimum wage is too low.

Black neighborhoods and low-wage, essential workers will bear the brunt of the coming eviction crisis. But a simple extension of the CDC moratorium isn’t the answer. The eviction crisis won’t be solved if we don’t address why residents have difficulty paying rent to begin with.

Read More

Continue Reading

Trending